Oncology & Cancer
New gene discovered driving drug resistance
Scientists in Salford, U.K., have identified a gene which is 'revving the engine of cancer' against the world's most common breast cancer drug.
Apr 4, 2017
0
0
Page 4 - News tagged with tamoxifen
Oncology & Cancer
Women experiencing menopausal symptoms less likely to adhere to medication in breast cancer prevention trial
Among women enrolled in the International Breast Cancer Intervention Study I (IBIS-I), those who had certain symptoms of menopause—nausea/vomiting and headaches—were significantly less likely to be adherent to the assigned ...
Dec 12, 2016
0
0
Oncology & Cancer
Naturally occurring symptoms may be mistaken for tamoxifen side-effects
Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer Symposium today (Friday).
Dec 9, 2016
0
0
Oncology & Cancer
Tamoxifen, AI therapies linked to reduced risk for contralateral breast cancer in community health
In patients with invasive breast cancer treated in a general community health care setting, tamoxifen therapy was associated with reduced risTamoxifen, AI therapies linked to reduced risk for contralateral breast cancer in ...
Oct 6, 2016
0
0
Oncology & Cancer
Study may help reassure women taking tamoxifen for breast cancer
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
Sep 15, 2016
0
3
Oncology & Cancer
Tamoxifen resistance linked to high estrogen levels in utero
An animal study suggests that resistance to tamoxifen therapy in some estrogen receptor positive breast cancers may originate from in utero exposure to endocrine disrupting chemicals. The study provides a new path forward ...
Sep 8, 2016
0
0
Oncology & Cancer
Scientists identify genes that disrupt response to breast cancer treatment
Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.
Sep 7, 2016
0
0
Oncology & Cancer
Sleep hormone melatonin helps breast cancer drug kill more cancer cells
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects. In a new study published in Colloids and Surfaces ...
Jun 14, 2016
0
32
Oncology & Cancer
Study may help reassure women taking tamoxifen for breast cancer
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
Jun 6, 2016
0
3
Oncology & Cancer
Two years of tamoxifen offers long-term survival benefit
(HealthDay)—For premenopausal women with breast cancer, two years of tamoxifen is associated with long-term survival benefit, according to a study published online May 9 in the Journal of Clinical Oncology.
May 12, 2016
0
5
